APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

The field of drug discovery faces many time-honored challenges. These include high costs, long development times and high rates of failure. The rise of artificial intelligence (AI) technology has been ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

3 CDMOs offer a wide range of comprehensive services to pharmaceutical companies, some of which can include supporting formulation development, upscaling current drug processes, clinical trial ...

That process is when manufacturers figure out what compounds should qualify as candidates for new medicines. The pharmaceutical company, which makes drugs like Lantus insulin jabs and Plavix blood ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

Dr Kaitin writes and speaks frequently on factors that contribute to the slow pace and high cost of pharmaceutical R&amp,D and the impact of efforts to speed the drug development process.

“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...